SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet's GOOG is trending due to growing investor confidence in its AI capabilities, particularly with the recent unveiling of Gemini 3, which is seen as a strong competitor to existing AI models. Community discussion revolves around GOOG potentially overtaking NVDA in market capitalization, with some analysts suggesting Google's long-term growth potential is being re-evaluated, leading to a shift in market sentiment.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet (GOOGL) is trending as investors discuss its potential to lead in AI, fueled by positive reviews of its Gemini 3 model and a recent investment by Berkshire Hathaway. Community members are weighing in on whether the stock's rapid growth is sustainable, while highlighting its competitive position against companies like Nvidia and OpenAI. Some traders are noting technical indicators that may signal a pullback is coming.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is trending upwards as the community discusses potential M&A activity and positive momentum within the biotech sector. Positive clinical data and new FDA pathways are also sparking interest, while some analysts point to attractive valuations compared to peers. Concerns about data integrity for specific companies are also circulating.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions around potential investigations related to Jeffrey Epstein, its relationship with crypto companies like $MSTR, and overall sentiment regarding the financial sector. Some traders are considering shorting the stock, while others point to positive technical indicators and potential upside. The community is also discussing JPM's role in the broader market and its impact on individual stocks.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as community members rally around its meme-driven narrative and organic growth on the SOL network. The community, known for its active presence and lighthearted approach, emphasizes that the "infection" is spreading, with community members using the hashtag #PMV. Participants suggest that the coin's current levels present an attractive entry point.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending amid discussions about its role in AI, particularly following reports that Google's Gemini 3 model utilizes Broadcom's TPUs, sparking debates about competition with Nvidia. Bullish sentiment and high price targets are fueled by expectations of strong earnings, while some traders are closely monitoring technical indicators and potential pullbacks. The community is also weighing the stock's valuation and its long-term potential within the growing AI landscape.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending amid discussions about immigration policies and detention facilities, with community members sharing news articles and discussing potential impacts on the company. Some traders are highlighting options strategies, while others are debating the company's financial outlook and potential for government contracts in light of political developments. The stock's valuation and buyback program are also key talking points.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

Karrat is trending as community members anticipate a potential run, with some eyeing a 10x increase. Talk centers on accumulating the token, especially below a certain price point, with expectations that Karrat could trade independently of larger cryptocurrencies like Bitcoin and Ethereum. Some traders point to the gaming sector and partnerships as potential catalysts for future growth.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad ($MON) is drawing mixed reactions, with some users alleging VC rug pulls and others speculating on potential Coinbase involvement or range formation. The community is actively discussing bottom price discovery and comparing it to established blockchains like Solana and Ethereum, while also pointing out concerns about low engagement.

Mason Capital Fund Trust - Fundamentals First ETF

KNOW Labs is trending, with discussions focusing on the company's plan to apply for listing on the NYSE American under the symbol "KNW." The community is also comparing KNOW's technology to competitors in the medical device space, specifically highlighting its non-invasive glucose monitoring device. Some users are speculating about a potential gamma squeeze and NASDAQ listing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are currently covering the firm...

Ventures L.P. 5Am Sells 200,000 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Ventures L.P. 5Am sold 200,000 shares of Entrada Therapeutics stock in a transaction that occurred on Friday, November...

Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Director Sells 200,000 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) Director Kush Parmar sold 200,000 shares of the company's stock in a transaction on Friday, November 14th. The stock was sold at an average...

Bros. Advisors Lp Baker Acquires 46,434 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bros. Advisors Lp Baker purchased 46,434 shares of Entrada Therapeutics stock in a transaction dated Tuesday, November...

Insider Buying: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Buys 30,874 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bros. Advisors Lp Baker acquired 30,874 shares of the firm's stock in a transaction dated Monday, November 10th. The stock...

Bros. Advisors Lp Baker Acquires 100,736 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bros. Advisors Lp Baker bought 100,736 shares of the company's stock in a transaction that occurred on Wednesday, November...

Insider Buying: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Purchases 46,434 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bros. Advisors Lp Baker acquired 46,434 shares of the stock in a transaction dated Tuesday, November 11th. The stock was...

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Misses Expectations By $0.02 EPS

Entrada Therapeutics (NASDAQ:TRDA - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($1.06) earnings per share (EPS) for the quarter, missing analysts' consensus...

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) delivered earnings and revenue surprises of -1.92% and -69.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Bristol Myers Squibb (BMY) Q3 Earnings and Revenues Surpass Estimates

Bristol Myers (BMY) delivered earnings and revenue surprises of +10.14% and +3.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Entrada Therapeutics Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TRDA News

TRDAEntrada Therapeutics Inc